CN Stock MarketDetailed Quotes
301033 Medprin Regenerative Medical Technologies
- 46.32
- -0.54-1.15%
Market Closed Dec 12 15:00 CST
3.08BMarket Cap45.15P/E (TTM)
46.78High45.28Low11.47KlotVolume46.47Open46.86Pre Close52.70MTurnover2.05%Turnover Ratio75.32P/E (Static)66.52MShares57.3252wk High4.58P/B2.60BFloat Cap21.9752wk Low56.23Limit Up56.06MShs Float84.87Historical High37.49Limit Down3.20%Amplitude21.97Historical Low0.40Dividend TTM45.95Avg Price5.51KlotAsk0.86%Div YieldTTM100Lot Size5.58KlotBid
Medprin Regenerative Medical Technologies Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 33.92%219.23M | 34.09%141.24M | 24.16%66.48M | 11.37%236.67M | 6.28%163.7M | 5.07%105.33M | 22.60%53.54M | 24.21%212.5M | 31.34%154.04M | 29.88%100.25M |
| Refunds of taxes and levies | 223.43%1.03M | 106.70%657K | -3.51%141.35K | 6.19%2.51M | -82.02%319.01K | -80.65%317.85K | -70.51%146.5K | -56.02%2.36M | 57.05%1.77M | 162.27%1.64M |
| Cash received relating to other operating activities | -72.30%9.5M | -46.34%8.02M | -45.33%7.01M | 395.78%39.12M | 695.24%34.29M | 607.74%14.95M | 1,419.86%12.82M | -67.80%7.89M | -69.80%4.31M | -78.59%2.11M |
| Cash inflows from operating activities | 15.86%229.76M | 24.31%149.92M | 10.70%73.63M | 24.94%278.3M | 23.85%198.31M | 15.95%120.59M | 47.76%66.51M | 10.85%222.75M | 20.68%160.12M | 18.62%104M |
| Goods services cash paid | 96.74%33.09M | 203.11%21.54M | 43.48%7.84M | -45.72%16.96M | -2.26%16.82M | -36.69%7.11M | -21.18%5.46M | 63.16%31.24M | 32.70%17.21M | 22.24%11.22M |
| Staff behalf paid | 4.22%55.04M | 2.09%38.52M | -2.19%22.98M | 5.26%66.87M | 0.95%52.82M | 0.91%37.73M | -0.12%23.5M | 20.02%63.53M | 18.72%52.32M | 23.45%37.39M |
| All taxes paid | 123.91%28.22M | 120.76%20.67M | 166.59%8.85M | 141.82%21.88M | 149.06%12.6M | 253.08%9.36M | 85.17%3.32M | -4.89%9.05M | -39.49%5.06M | -56.08%2.65M |
| Cash paid relating to other operating activities | 11.86%50.03M | 17.37%34.78M | 22.14%18.07M | -8.09%64.91M | -17.89%44.73M | -13.70%29.63M | -2.11%14.8M | 33.62%70.62M | 51.16%54.47M | 60.04%34.34M |
| Cash outflows from operating activities | 31.05%166.38M | 37.79%115.52M | 22.66%57.74M | -2.20%170.61M | -1.62%126.96M | -2.06%83.84M | -0.61%47.07M | 29.75%174.44M | 27.23%129.05M | 27.84%85.61M |
| Net cash flows from operating activities | -11.17%63.38M | -6.41%34.4M | -18.25%15.89M | 122.91%107.69M | 129.63%71.35M | 99.80%36.76M | 925.83%19.43M | -27.37%48.31M | -0.60%31.07M | -11.18%18.4M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -18.37%352.26M | 0.51%262.03M | -16.50%116.27M | -49.42%575.08M | -52.33%431.54M | -57.92%260.7M | -52.73%139.25M | 29.78%1.14B | 145.78%905.22M | 314.13%619.54M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -37.16%18.5K | ---- | ---- | -52.19%29.44K | -51.60%29.44K | 2,199.84%29.44K | ---- | 478.33%61.57K | 8,589.14%60.82K | --1.28K |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | --203.16K | --203.16K | --203.12K | ---- | ---- | ---- |
| Cash inflows from investing activities | -18.41%352.28M | 0.42%262.03M | -16.62%116.27M | -49.42%575.11M | -52.30%431.78M | -57.88%260.94M | -52.67%139.45M | 29.79%1.14B | 143.23%905.28M | 308.23%619.54M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -16.37%25.63M | 41.30%22.41M | 58.64%10.35M | -70.52%40.09M | -68.89%30.65M | -79.53%15.86M | -84.56%6.53M | -10.97%135.96M | -6.45%98.5M | 26.10%77.45M |
| Cash paid to acquire investments | -32.61%294.73M | -33.90%179.8M | -43.45%89.1M | -37.00%616.92M | -45.85%437.36M | -48.24%272M | -37.26%157.56M | -5.70%979.17M | 59.12%807.67M | 272.42%525.48M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.45M | ---- | ---- |
| Cash outflows from investing activities | -31.55%320.36M | -29.75%202.21M | -39.39%99.45M | -41.26%657.01M | -48.35%468.01M | -52.26%287.86M | -44.07%164.09M | -6.09%1.12B | 47.86%906.17M | 197.72%602.93M |
| Net cash flows from investing activities | 188.11%31.92M | 322.22%59.83M | 168.27%16.82M | -541.44%-81.9M | -3,972.18%-36.23M | -262.10%-26.92M | -2,110.02%-24.63M | 105.89%18.55M | 99.63%-889.68K | 132.72%16.61M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --9.31M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | --9.31M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Borrowing repayment | 97.52%50.3M | 97.52%50.3M | ---- | 9.15%26.75M | --25.47M | --25.47M | --25.47M | --24.51M | ---- | ---- |
| Dividend interest payment | 83.01%26.26M | 89.72%26.26M | -14.47%478.33K | 89.75%15.28M | 105.89%14.35M | 121.78%13.84M | --559.25K | --8.05M | --6.97M | --6.24M |
| Cash payments relating to other financing activities | 849.22%13.04M | 1,174.70%12.53M | 1,829.95%9.51M | -30.07%1.86M | -75.44%1.37M | -33.53%982.65K | -33.23%492.5K | -95.30%2.66M | -89.98%5.59M | -1.03%1.48M |
| Cash outflows from financing activities | 117.53%89.6M | 121.11%89.09M | -62.35%9.98M | 24.61%43.9M | 227.88%41.19M | 421.91%40.29M | 3,495.00%26.52M | -37.84%35.23M | -77.48%12.56M | 416.81%7.72M |
| Net cash flows from financing activities | -94.92%-80.29M | -121.11%-89.09M | 62.35%-9.98M | -24.61%-43.9M | -227.88%-41.19M | -421.91%-40.29M | -3,495.00%-26.52M | -114.23%-35.23M | -105.06%-12.56M | -117.59%-7.72M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -31.11%105.51K | -13.81%216.96K | 93.72%-13.11K | -99.18%24.27K | -73.67%153.16K | 104.13%251.73K | -54.44%-208.93K | 807.24%2.97M | 347.89%581.71K | 166.78%123.32K |
| Net increase in cash and cash equivalents | 355.48%15.12M | 117.74%5.36M | 171.13%22.71M | -152.26%-18.09M | -132.51%-5.92M | -210.20%-30.2M | -1,495.72%-31.93M | 2,668.07%34.61M | -53.01%18.2M | 100.51%27.41M |
| Add:Begin period cash and cash equivalents | -40.40%26.68M | -40.40%26.68M | -40.42%26.67M | 340.69%44.76M | 340.69%44.76M | 340.69%44.76M | 340.69%44.76M | -11.71%10.16M | -11.71%10.16M | -11.71%10.16M |
| End period cash equivalent | 7.60%41.8M | 120.03%32.03M | 284.65%49.38M | -40.40%26.68M | 36.98%38.84M | -61.24%14.56M | 57.39%12.84M | 340.69%44.76M | -43.55%28.36M | 49.22%37.57M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
